Showing results (221-230 of 498) with videos related to

Sort By:
Pageof 50
Antimicrobial Agents and Chemotherapy|August 23, 2023
Discovery and characterization of antimycobacterial nitro-containing compounds with distinct mechanisms of action and in vivo efficacyIfeanyichukwu E Eke, John T Williams, Elizabeth R Haiderer, et al.
The Journal of Surgical Research|May 23, 2001
Reverse transcriptase-polymerase chain reaction (RT-PCR) analysis of nonsentinel nodes following completion lymphadenectomy for melanomaW R Wrightson, S L Wong, M J Edwards, et al.
Molecular Pain|May 10, 2015
Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skinFrank L Rice, Phillip J Albrecht, James P Wymer, et al.
Pain Reports|February 20, 2024
Cutaneous targets for topical pain medications in patients with neuropathic pain: individual differential expression of biomarkers supports the need for personalized medicinePhillip J Albrecht, Yi Liu, George Houk, et al.
Rhinology|July 15, 2009
Olfactory detection thresholds and pleasantness of a food-related and a non-food odour in hunger and satietyJ Albrecht, T Schreder, A M Kleemann, et al.
Neurobiology of Disease|June 28, 2003
Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 productionPhillip J Albrecht, Joshua C Murtie, Jennifer K Ness, et al.
Chemical Senses|August 15, 2008
Investigation of breathing parameters during odor perception and olfactory imageryA M Kleemann, R Kopietz, J Albrecht, et al.
Gastroenterology|August 1, 1991
Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitisX Causse, H Godinot, M Chevallier, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 17, 2022
Keratinocyte Biomarkers Distinguish Painful Diabetic Peripheral Neuropathy Patients and Correlate With Topical Lidocaine ResponsivenessPhillip J Albrecht, George Houk, Elizabeth Ruggiero, et al.
Hepatology (Baltimore, Md.)|June 1, 1994
Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patientsG L Davis, J Y Lau, M S Urdea, et al.
Pageof 50